C12Y 603/04
Ligases forming carbon-nitrogen bonds: other carbon-nitrogen ligases
Official title: Other carbon-nitrogen ligases (6.3.4)
C12Y603/04 (Ligases forming carbon-nitrogen bonds: other carbon-nitrogen ligases) appears on 55 US grants and 107 published applications in this corpus.
Search patents in C12Y- Granted patents
- 55
- Published applications
- 107
- Assignees
- 77
- Inventors
- 267
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 0 |
| 2003 | 0 | 0 |
| 2004 | 1 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 2 | 3 |
| 2013 | 2 | 1 |
| 2014 | 0 | 2 |
| 2015 | 1 | 4 |
| 2016 | 2 | 3 |
| 2017 | 2 | 6 |
| 2018 | 2 | 4 |
| 2019 | 2 | 8 |
| 2020 | 3 | 7 |
| 2021 | 3 | 8 |
| 2022 | 11 | 15 |
| 2023 | 5 | 6 |
| 2024 | 4 | 10 |
| 2025 | 6 | 13 |
| 2026 | 5 | 10 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 603/04005Argininosuccinate synthase11
- C12Y 603/04016Carbamoyl-phosphate synthase10
- C12Y 603/04002Ctp synthase9
- C12Y 603/04015Biotin-[acetyl-coa-carboxylase] ligase9
- C12Y 603/04003Formate--tetrahydrofolate ligase6
- C12Y 603/04006Urea carboxylase4
- C12Y 603/04004Adenylosuccinate synthase3
- C12Y 603/0401Biotin--[propionyl-coa-carboxylase ] ligase3
All 20 subgroupsShow fewer
- C12Y 603/04009Biotin--[methylmalonyl-coa-carboxytransferase] ligase1
- C12Y 603/04011Biotin--[methylcrotonoyl-coa-carboxylase] ligase1
- C12Y 603/04012Glutamate--methylamine ligase1
- C12Y 603/04001Gmp synthase0
- C12Y 603/04007Ribose-5-phosphate--ammonia ligase0
- C12Y 603/04008Imidazoleacetate--phosphoribosyldiphosphate ligase0
- C12Y 603/04013Phosphoribosylamine-glycine ligase0
- C12Y 603/04014Biotin carboxylase0
- C12Y 603/04017Formate--dihydrofolate ligase0
- C12Y 603/040185-imidazole ribonucleotide synthase0
- C12Y 603/04019Trna-lysidine synthetase0
- C12Y 603/04027-cyano-7-deazaguanine synthase0
Recent patents
- Genetically engineered microorganism capable of growing on formate, methanol, methane or CO214 Apr 2026US 12,600,974 B2
- Gene engineering bacteria for producing L-arginine and construction method and application of gene engineering bacteria10 Mar 2026US 12,571,013 B2Ningxia Eppen Biotech Co., Ltd
- Modulation of protein degradation10 Feb 2026US 12,546,776 B2Orionis Biosciences BV
- MRNA therapy for argininosuccinate synthetase deficiency27 Jan 2026US 12,533,402 B2Translate Bio, Inc.
- Peptide-receptive MHC-I complex compositions and methods27 Jan 2026US 12,534,510 B2The Regents of the University of California
- Methods for carbon-conserving cell-free bioproduction27 Aug 2026US 2026/0250724 A1Battelle Memorial Institute
- Bioelectric hybrid system producing lactic acid from carbon dioxide20 Aug 2026US 2026/0242832 A1Korea Advanced Institute of Science and Technology
- A method for detecting protein targets of an enzyme using a biotin ligase20 Aug 2026US 2026/0243776 A1Leibniz-Institut Fur Alternsforschung—Fritz-Lipmann-Institut E.V. (Fli)
- Method for the fermentative production of guanidinoacetic acid using a microorganism comprising a heterologous l-threonine 3-dehydrogenase gene (tdh) and a glycine c-acetyltransferase gene (kbl)6 Aug 2026US 2026/0226404 A1Evonik Operations GmbH
- Fermentative production guanidinoacetic acid (gaa) from serine by attenuating l serine ammonia lyase activity in microorganisms30 Jul 2026US 2026/0218253 A1Evonik Operations GmbH
Most cited
By later US patents
- Therapeutic methods relating to human carbamyl phosphate synthetase I polymorphism112US 6,743,823 B1Vanderbilt University · 2004
- Cell-free preparation of carbapenems13US 9,469,861 B2GreenLight Biosciences, Inc. · 2016
- Regulated biocircuit systems11US 11,446,398 B2Obsidian Therapeutics, Inc. · 2022
- Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto9US 6,346,382 B1Vanderbilt University · 2002
- Therapeutic methods employing nitric oxide precursors5US 8,188,147 B2Vanderbilt University · 2012